服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-TNFSF14/CD258 mAbs [Quisovalimab Biosimilar] (MABL-5129) | MABL-5129 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Idiotope of anti-NeuGc-ganliosides mAbs [Racotumomab Biosimilar] (MABL-5130) | MABL-5130 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL4R/CD124 mAbs [Rademikibart Biosimilar] (MABL-5131) | MABL-5131 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-FN extracellular domain B mAbs [Radretumab Biosimilar] (MABL-5132) | MABL-5132 | ELISA, FACS, Functional assay, in vivo binding | E, Kappa |
| Anti-Rabies Virus Antigenic Site III mAbs [Rafivirumab Biosimilar] (MABL-5133) | MABL-5133 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TNFRSF18/CD357/GITR mAbs [Ragifilimab Biosimilar] (MABL-5134) | MABL-5134 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Ragistomig Biosimilar] (MABL-5135) | MABL-5135 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-PCSK9 mAbs [Ralpancizumab Biosimilar] (MABL-5136) | MABL-5136 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CDH6 mAbs [Raludotatug Biosimilar] (MABL-5137) | MABL-5137 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Ralzapastotug Biosimilar] (MABL-5138) | MABL-5138 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;GPRC5D mAbs [Ramantamig1 Biosimilar] (MABL-5139) | MABL-5139 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Ramantamig2 Biosimilar] (MABL-5140) | MABL-5140 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Plutavimab Biosimilar] (MABL-5109) | MABL-5109 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Porgaviximab Biosimilar] (MABL-5110) | MABL-5110 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Pradusinstobart Biosimilar] (MABL-5111) | MABL-5111 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ACVR1 mAbs [Prafnosbart Biosimilar] (MABL-5112) | MABL-5112 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ALCAM/CD166 mAbs [Praluzatamab Biosimilar] (MABL-5113) | MABL-5113 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SNCA/PARK1/PARK4 mAbs [Prasinezumab Biosimilar] (MABL-5114) | MABL-5114 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CEACAM5/CD66e mAbs [Precemtabart Biosimilar] (MABL-5115) | MABL-5115 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ICOSLG mAbs [Prezalumab Biosimilar] (MABL-5116) | MABL-5116 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn